Endra life sciences inc. (NDRA)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16
Assets
Cash

3,102

6,174

2,275

2,267

3,925

6,471

637

2,205

3,149

5,601

6,977

7,524

133

144

Accounts receivable

-

-

-

-

-

-

12

11

11

6

-

-

-

0

Prepaid expenses

373

116

206

243

105

145

328

318

38

67

101

4

1

0

Inventory

174

113

127

74

74

59

0

279

245

191

131

133

40

40

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

75

-

Other current assets

121

130

366

366

273

273

21

18

17

14

12

10

15

10

Total current assets

3,772

6,535

2,976

2,951

4,378

6,949

998

2,834

3,463

5,882

7,222

7,672

265

195

Other Assets
Fixed assets, net

237

236

218

238

258

273

293

211

226

241

256

272

279

295

Right of use assets

389

404

420

-

-

0

-

-

-

-

-

-

-

-

Total assets

4,398

7,176

3,615

3,190

4,636

7,222

1,291

3,045

3,690

6,123

7,479

7,944

545

490

Liabilities and Stockholders' Equity
Current Liabilities
Accounts payable and accrued liabilities

1,444

1,708

1,198

1,366

835

-

1,068

751

-

-

-

-

-

-

Convertible notes payable, net of discount

-

-

-

-

-

-

681

353

-

-

-

-

-

-

Accounts payable and accrued liabilities

-

-

-

-

-

974

-

-

860

848

312

162

623

434

Notes payable

-

-

-

-

-

-

-

-

-

-

0

0

50

50

Convertible notes payable, related party, net of discount

-

-

-

-

-

-

-

-

-

-

0

0

102

99

Convertible notes payable, net of discount

38

298

590

-

-

0

-

-

-

-

0

0

1,149

800

Lease liabilities, current portion

68

66

65

-

-

0

-

-

-

-

-

-

-

-

Total current liabilities

1,551

2,072

1,853

-

-

974

-

-

-

-

312

162

1,924

1,384

Long Term Liabilities
Lease liabilities

325

342

358

-

-

0

-

-

-

-

-

-

-

-

Total Long Term Liabilities

325

342

358

-

-

0

-

-

-

-

-

-

-

-

Total liabilities

1,876

2,415

2,212

1,366

835

974

1,749

1,104

860

848

312

162

1,924

1,384

Stockholders' Equity
Preferred stock

-

-

0

0

0

-

0

0

0

0

0

0

0

0

Common stock, $0.0001 par value; 50,000,000 shares authorized; 13,553,005 and 8,421,401shares issued and outstanding

1

0

0

0

0

0

0

0

0

0

0

0

0

0

Additional paid in capital

50,982

49,933

37,590

34,598

34,241

33,939

24,868

24,507

23,550

23,170

22,768

22,473

11,790

11,543

Stock payable

-78

-43

-

-

-

0

-

-

-

-

0

0

90

81

Accumulated deficit

-48,540

-45,217

-36,188

-32,774

-30,440

-27,691

-25,326

-22,567

-20,720

-17,895

-15,600

-14,691

-13,260

-12,518

Total stockholders' equity

2,522

4,760

1,402

1,824

3,801

6,248

-457

1,940

2,829

5,275

7,167

7,782

-1,379

-893

Total liabilities and stockholders' equity

4,398

7,176

3,615

3,190

4,636

7,222

1,291

3,045

3,690

6,123

7,479

7,944

545

490

Series A Convertible Preferred Stock
Preferred stock

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Series B Convertible Preferred Stock
Preferred stock

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Preferred Class A
Preferred stock

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Total Stockholders' Equity

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Preferred Class B
Preferred stock

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Total Stockholders' Equity

-

-

-

-

-

0

-

-

-

-

-

-

-

-